NDC 68001-541

Bortezomib

Bortezomib

Bortezomib is a Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Bortezomib.

Product ID68001-541_e6591c11-be30-dd6f-e053-2995a90a766e
NDC68001-541
Product TypeHuman Prescription Drug
Proprietary NameBortezomib
Generic NameBortezomib
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2022-07-31
Marketing CategoryANDA /
Application NumberANDA209622
Labeler NameBluePoint Laboratories
Substance NameBORTEZOMIB
Active Ingredient Strength4 mg/3.5mL
Pharm ClassesProteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68001-541-36

1 VIAL, SINGLE-USE in 1 CARTON (68001-541-36) > 3.5 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2022-07-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Bortezomib" or generic name "Bortezomib"

NDCBrand NameGeneric Name
0143-9098bortezomibbortezomib
0409-1700BortezomibBortezomib
0409-1703BORTEZOMIBBORTEZOMIB
0409-1704BORTEZOMIBBORTEZOMIB
0781-3258bortezomibbortezomib for injection
10019-991BORTEZOMIBbortezomib
25021-244BORTEZOMIBBORTEZOMIB
43598-426BortezomibBortexomib
43598-865BortezomibBortexomib
50742-484BortezomibBortezomib
51817-586Bortezomibbortezomib
55150-337BORTEZOMIBBORTEZOMIB
60505-6050BORTEZOMIBbortezomib
63323-721BortezomibBortezomib
63323-821BortezomibBortezomib
67184-0530BortezomibBortezomib
68001-534BortezomibBortezomib
68001-540BortezomibBortezomib
68001-541BortezomibBortezomib
70511-161Bortezomibbortezomib
70511-162Bortezomibbortezomib
70710-1411BORTEZOMIBBORTEZOMIB
70771-1708BORTEZOMIBBORTEZOMIB
70860-225Bortezomibbortezomib
71288-118BortezomibBortezomib
72205-183BortezomibBortezomib
72266-243Bortezomibbortezomib
72266-244Bortezomibbortezomib
63020-049VELCADEbortezomib

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.